Extracorporeal shock-wave lithotripsy (ESWL) for treatment of urolithiasis

https://doi.org/10.1016/0090-4295(84)90243-7Get rights and content

Abstract

We present our experience with extracorporeal shock wave lithotripsy (ESWL) and the new therapeutic aspects it has generated. The current state of technology also will be discussed.

References (21)

There are more references available in the full text version of this article.

Cited by (256)

  • Shock wave and mesenchymal stem cells as treatment in the acute phase of spinal cord injury: A pilot study

    2022, Rehabilitacion
    Citation Excerpt :

    Shock waves are a standard therapy in muscular and tendinous rehabilitation,11,12 commonly used in medical care systems with significant rates of success,11,12 associated with angiogenic growth and proliferating factors as eNOS, VEGF, and PCNA.12 Its first medical use was in 1984 by Chaussy et al.13 as a lithotripsy therapy. Since then, its use in urology has been extended.14

  • Emerging Technologies in Lithotripsy

    2019, Urologic Clinics of North America
    Citation Excerpt :

    Extracorporeal treatment of nephrolithiasis has been a mainstay surgical therapy for the treatment of nephrolithiasis since the original experience with the HM-3 lithotripter was reported in 1984.1

View all citing articles on Scopus

Sponsored by Bundesministerium Fir Forschung and Technologie.

View full text